Pertussis in Infants European Network

Setting up a sentinel system to assess the burden of whooping cough in EU/EEA

In the last ten years pertussis has re-emerged in many regions including the European Union (EU) and European Economic Area (EEA), despite high and stable vaccine coverage with the primary series of acellular pertussis vaccine. Pertussis can lead to severe disease in infants.

PERTINENT aims at setting up a European hospital network to address key questions on the burden of pertussis in infants less than one year of age, as well as the vaccine effectiveness and impact of different pertussis vaccination strategies in the EU/EEA.

The project “Setting up a sentinel system to assess the burden of whooping cough in EU/EEA” is funded by ECDC, coordinated by EpiConcept and involves seven study sites and four expert partners from 10 EU/EEA member states.


The project started in September 2015 and is planned to last four years.


News from the network and Pertussis in Europe and beyond

Links to monitoring tools

Three monitoring tools are available if needed:
  • Web-based questionnaire
  • Web-based recruitment table
  • Excel template for data collection

Please visit the "Monitoring tools" section for more information.


  • The second PERTINENT Technical Meeting was held in Rome 11-12 June 2018
    Please visit the restricted area: "Technical Meeting 2018"

  • The second PERTINENT Annual meeting was held in Lisbon, 13-14 June 2017, gathering all the PERTINENT partners, ECDC representatives, network coordination and other external experts.
    Please visit the restricted area: "Annual Meeting 2017"